CSG Stock: AMX Upgrade and €300M German Boost Overshadowed by 60% Crash and Extreme Volatility

Czechoslovak Group secures €300M German contract and Euronext AMX listing, yet shares drop 11% in a week amid extreme volatility and oversold conditions.

The Czechoslovak Group has received two rare pieces of good news this week – a fresh €300 million contract from Berlin and a promotion to Euronext’s AMX index – yet the defence stock continues to hemorrhage value. Shares closed Tuesday at €14.30, down 3.22% on the day and nearly 11% lower over the past seven days, extending a rout that has wiped out more than 60% from the January record high of €36.05.

Germany’s latest allocation brings the total Berlin has committed to the Czech-led munitions initiative to €1.3 billion, with the new tranche earmarked for around 50,000 rounds of long-range ammunition. The Federal Republic remains the program’s largest backer. Just days earlier, CSG locked in additional orders for artillery fuzes from two NATO members, each contract valued in the high double-digit millions of euros.

The AMX listing, announced after Tuesday’s closing bell, adds CSG to the benchmark index for mid-cap stocks on Euronext Amsterdam. The index tracks the 25 most liquid non-AEX companies and serves as the underlying for structured products, exchange-traded funds and futures. For a stock that has been in freefall since its January IPO – the world’s largest defence listing at a €25 billion market capitalisation and €3.8 billion in proceeds – the index inclusion offers at least a psychological lift and could trigger passive inflows from funds that replicate the AMX.

Yet the positive headlines are colliding with brutal chart dynamics. The relative strength index has sunk to 28.8, deep in oversold territory, while the annualised 30-day volatility stands at a staggering 77%. Such extreme price swings underscore how hypersensitive the defence sector has become to every shift in the geopolitical narrative. Meanwhile, the number of nations participating in the munitions initiative has actually shrunk from 18 to nine, even as production volumes have surged – the coalition has so far delivered 4.4 million shells.

The disconnect between CSG’s operational performance and its share price is widening by the day. First-quarter 2026 revenue came in at €1.544 billion, up 13.8% year-on-year, with operating EBIT rising 8.7% to €372 million. Management confirmed its full-year guidance of €7.4 billion to €7.6 billion in revenue and an EBIT margin between 24% and 25%. On the capacity front, CSG expects to ramp production of large-calibre ammunition to around 850,000 rounds by the end of 2026, up from 550,000 last year.

The stock now trades at a fraction of its IPO valuation, with the 60% collapse leaving it in what technicians would call a massively oversold condition. Whether the AMX admission and the steady flow of government contracts can eventually stabilise the price will be tested when CSG releases its half-year results on 7 August – the next scheduled moment when hard numbers might start to realign the market’s perception with the underlying business reality.